Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma
Xie, Q., Bradley, R., Kang, L., Koeman, J., Ascierto, M. L., Worschech, A., De Giorgi, V., Wang, E., Kefene, L., Su, Y., Essenburg, C., Kaufman, D. W., DeKoning, T., Enter, M. A., O'Rourke, T. J., MarVolume:
109
Language:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.1119059109
Date:
January, 2012
File:
PDF, 704 KB
english, 2012